MCID: ACT075
MIFTS: 57

Acute Myocardial Infarction

Categories: Blood diseases, Cardiovascular diseases, Genetic diseases, Oral diseases, Respiratory diseases

Aliases & Classifications for Acute Myocardial Infarction

MalaCards integrated aliases for Acute Myocardial Infarction:

Name: Acute Myocardial Infarction 39 12 56 15 17 74

Classifications:



External Ids:

Disease Ontology 12 DOID:9408
ICD9CM 36 410 410.9 410.90
NCIt 51 C35204
SNOMED-CT 69 57054005
ICD10 34 I21 I21.9
UMLS 74 C0155626

Summaries for Acute Myocardial Infarction

MalaCards based summary : Acute Myocardial Infarction is related to cardiac rupture and acute anterolateral myocardial infarction, and has symptoms including angina pectoris and chest pain. An important gene associated with Acute Myocardial Infarction is MIR208B (MicroRNA 208b), and among its related pathways/superpathways is A-beta Pathways: Plaque Formation and APP Metabolism. The drugs Dopamine and Metoclopramide have been mentioned in the context of this disorder. Affiliated tissues include heart, bone and bone marrow, and related phenotype is cardiovascular system.

Related Diseases for Acute Myocardial Infarction

Diseases in the Myocardial Infarction family:

Myocardial Infarction 2 Acute Myocardial Infarction
Posterior Myocardial Infarction

Diseases related to Acute Myocardial Infarction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 500)
# Related Disease Score Top Affiliating Genes
1 cardiac rupture 33.1 CRP PLAT
2 acute anterolateral myocardial infarction 32.8 ACE PIK3C2A
3 myocardial infarction 32.2 ACE ADRB1 CDKN2B-AS1 CRP F3 FABP3
4 cardiogenic shock 32.2 NPPB PIK3C2A PLAT
5 angina pectoris 31.9 ACE CRP NPPB PIK3C2A PLAT
6 thrombosis 31.8 F3 PLAT SELP
7 left bundle branch hemiblock 31.8 ACE NPPB TNNI3
8 ischemia 31.6 ACE MB PLAT SELP
9 myocarditis 31.6 MB NPPB TNNI3
10 atrial standstill 1 31.6 ACE ADRB1 NPPB TNNI3
11 cardiac arrest 31.4 ACE NPPB PIK3C2A
12 atrial fibrillation 31.4 ACE ADRB1 CRP NPPB PLAT SELP
13 ischemic heart disease 31.4 ACE CRP NPPB
14 antiphospholipid syndrome 31.3 F3 PLAT SELP
15 pericardial effusion 31.3 CRP NPPB PIK3C2A
16 coronary stenosis 31.3 ACE CRP NPPB PIK3C2A TNNI3
17 arteries, anomalies of 31.3 ACE CRP F3 MB NPPB PLAT
18 endocarditis 31.3 CRP PIK3C2A PLAT TNNI3
19 pulmonary edema 31.2 ACE CRP NPPB PIK3C2A
20 thrombocytosis 31.0 CRP F3 SELP
21 coronary artery anomaly 31.0 ACE ADRB1 CRP FABP3 MB NPPB
22 disseminated intravascular coagulation 30.9 F3 MB PIK3C2A PLAT
23 pulmonary embolism 30.9 CRP F3 FABP3 NPPB PLAT TNNI3
24 sleep apnea 30.8 ACE CRP NPPB
25 heart disease 30.8 ACE ADRB1 CRP F3 FABP3 NPPB
26 systolic heart failure 30.8 ACE ADRB1 CRP NPPB
27 cerebrovascular disease 30.7 ACE CRP PLAT SELP
28 respiratory failure 30.7 ACE CRP F3 PIK3C2A
29 congestive heart failure 30.7 ACE ADRB1 CDKN2B-AS1 MHRT NPPB
30 vascular disease 30.6 ACE CRP F3 PLAT SELP
31 platelet aggregation, spontaneous 30.6 PLAT SELP
32 arteriosclerosis 30.5 ACE CRP F3 SELP
33 peripheral vascular disease 30.5 ACE CRP F3 PLAT SELP
34 coronary heart disease 1 30.5 ACE ADRB1 CDKN2B-AS1 CRP NPPB PLAT
35 aortic valve disease 2 30.4 ACE CRP NPPB
36 toxic myocarditis 30.4 NPPB PIK3C2A TNNI3
37 stroke, ischemic 30.4 ACE CDKN2B-AS1 CRP F3 PLAT SELP
38 systemic scleroderma 30.3 ACE CRP SELP
39 chagas disease 30.3 ACE ADRB1 NPPB
40 marantic endocarditis 30.1 F3 PLAT
41 dilated cardiomyopathy 30.0 ACE ADRB1 CRP FABP3 MB MIR499A
42 intermediate coronary syndrome 29.9 ACE CRP F3 MB PIK3C2A PLAT
43 peripheral artery disease 29.9 ACE CDKN2B-AS1 CRP SELP
44 diabetes mellitus, noninsulin-dependent 29.7 ACE CDKN2B-AS1 CRP MIR29A PLAT
45 subendocardial infarction acute myocardial infarction 12.4
46 strictly posterior acute myocardial infarction 12.3
47 coronary artery disease, autosomal dominant, 1 11.5
48 acute inferoposterior infarction 11.4
49 acute inferolateral myocardial infarction 11.4
50 coronary artery disease, autosomal dominant 2 11.3

Comorbidity relations with Acute Myocardial Infarction via Phenotypic Disease Network (PDN): (show all 22)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Aortic Valve Disease 1
Cardiac Arrest Chronic Kidney Failure
Chronic Myocardial Ischemia Decubitus Ulcer
Deficiency Anemia Familial Atrial Fibrillation
Generalized Atherosclerosis Heart Disease
Hypertension, Essential Intermediate Coronary Syndrome
Ischemic Heart Disease Kidney Disease
Mitral Valve Disease Peripheral Vascular Disease
Protein-Energy Malnutrition Respiratory Failure
Schizophreniform Disorder Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Acute Myocardial Infarction:



Diseases related to Acute Myocardial Infarction

Symptoms & Phenotypes for Acute Myocardial Infarction

UMLS symptoms related to Acute Myocardial Infarction:


angina pectoris, chest pain

MGI Mouse Phenotypes related to Acute Myocardial Infarction:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.32 ACE ADRB1 CRP F3 FABP3 MB

Drugs & Therapeutics for Acute Myocardial Infarction

Drugs for Acute Myocardial Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 590)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 2,Phase 3,Not Applicable 62-31-7, 51-61-6 681
2
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
3
Morphine Approved, Investigational Phase 4,Phase 3,Not Applicable 57-27-2 5288826
4
Ticagrelor Approved Phase 4,Phase 2,Phase 3,Not Applicable 274693-27-5 9871419
5
Pravastatin Approved Phase 4 81093-37-0 54687
6
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 22916-47-8 4189
7
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53123-88-9 46835353 6436030 5284616
8
Abciximab Approved Phase 4,Phase 3,Phase 2,Not Applicable 143653-53-6
9
Everolimus Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 159351-69-6 6442177 70789204
10
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Not Applicable 120202-66-6, 113665-84-2 60606
11
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 50-78-2 2244
12
Thrombin Approved, Investigational Phase 4,Phase 3
13
Tenecteplase Approved Phase 4,Phase 3,Phase 2 191588-94-0
14
Bivalirudin Approved, Investigational Phase 4,Phase 3,Not Applicable 128270-60-0 16129704
15
Enoxaparin Approved Phase 4,Phase 3,Phase 2,Not Applicable 9005-49-6 772
16
Tirofiban Approved Phase 4,Phase 3,Not Applicable 144494-65-5 60947
17
Colchicine Approved Phase 4,Phase 3,Phase 2 64-86-8 6167 2833
18
Heparin Approved, Investigational Phase 4,Phase 3,Not Applicable 9005-49-6 772 46507594
19
Nicorandil Approved, Investigational Phase 4,Phase 3,Not Applicable 65141-46-0 47528
20
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
21
Desflurane Approved Phase 4 57041-67-5 42113
22
Metformin Approved Phase 4,Phase 2,Phase 3 657-24-9 14219 4091
23
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-66-6 32051
24
Insulin glargine Approved Phase 4,Phase 3,Not Applicable 160337-95-1
25
Paclitaxel Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 33069-62-4 36314
26
Pantoprazole Approved Phase 4 102625-70-7 4679
27
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
28
Glimepiride Approved Phase 4,Phase 3 93479-97-1 3476
29
Gliclazide Approved Phase 4,Phase 3 21187-98-4 3475
30
Glyburide Approved Phase 4,Phase 3 10238-21-8 3488
31
Pioglitazone Approved, Investigational Phase 4,Phase 3 111025-46-8 4829
32
Apixaban Approved Phase 4,Phase 3 503612-47-3 10182969
33
Rivaroxaban Approved Phase 4,Phase 3 366789-02-8
34
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 68521-88-0, 11128-99-7, 4474-91-3 172198 65143
35
Valsartan Approved, Investigational Phase 4,Phase 3 137862-53-4 60846
36
Dalteparin Approved Phase 4,Phase 3,Not Applicable 9005-49-6
37
Atorvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 134523-00-5 60823
38 Nutmeg Approved Phase 4,Phase 3
39
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 37350-58-6, 51384-51-1 4171
40
Lenograstim Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 135968-09-1
41
Sargramostim Approved, Investigational Phase 4,Phase 2,Phase 3 123774-72-1, 83869-56-1
42
Simvastatin Approved Phase 4,Phase 3,Phase 2,Not Applicable 79902-63-9 54454
43
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 58-61-7 60961
44
Chromium Approved Phase 4,Phase 3,Phase 2,Not Applicable 7440-47-3 27668
45
Furosemide Approved, Vet_approved Phase 4,Phase 3 54-31-9 3440
46
Amlodipine Approved Phase 4,Phase 3 88150-42-9 2162
47
Cobalt Approved, Experimental Phase 4,Phase 3,Phase 2,Not Applicable 7440-48-4 104729
48
Warfarin Approved Phase 4,Phase 3,Not Applicable 81-81-2 6691 54678486
49
Bezafibrate Approved, Investigational Phase 4 41859-67-0 39042
50
Streptokinase Approved, Investigational Phase 4,Phase 3 9002-01-1

Interventional clinical trials:

(show top 50) (show all 1341)
# Name Status NCT ID Phase Drugs
1 Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction Unknown status NCT02627950 Phase 4 Morphinhydrochloricum;Metoclopramide;Ticagrelor;Isotonic sodium chloride
2 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
3 Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study Unknown status NCT00688922 Phase 4 Pravastatin
4 Sirolimus Eluting Stenting in Acute Myocardial Infarction Unknown status NCT00288210 Phase 4
5 Anti-Restenosis After AMI by Erythropoietin Unknown status NCT00423020 Phase 4 Erythropoietin
6 Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction Unknown status NCT02524964 Phase 4 sodium tanshinone IIA sulfonate
7 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4 Microbubbles
8 Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI Unknown status NCT02268669 Phase 4
9 Treating Acute MI Patients With Aggrastat on Their Way to Hospital Unknown status NCT00300833 Phase 4 Tirofiban
10 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4 Epadel, Eicosapentaenoic acid
11 Post-MI PET Scan Imaging of Inflammation Unknown status NCT02281305 Phase 4 Colchicine
12 Colchicine in ST-elevation Myocardial Infarction Unknown status NCT01936285 Phase 4 Colchicine 2 mg loading dose; 0.5 mg bid for 5 days;Placebo
13 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
14 Evaluation of Neointimal Coverage of EES and BMS After Implantation in STEMI Patients by Optical Coherence Tomography Unknown status NCT01875835 Phase 4
15 Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI Unknown status NCT00229515 Phase 4
16 P3AMI Antiplatelet Trial Unknown status NCT02376283 Phase 4 Prasugrel;Clopidogrel;ticagrelor
17 The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients Unknown status NCT02850627 Phase 4 Tongguan capsule;placebo capsule
18 Vitamin D and Inflammatory Cytokine Levels After Acute Myocardial Infraction (MI) Unknown status NCT01115842 Phase 4 Vitamin D
19 Treatment of Reperfusion Event by Vitamin C Infusion Unknown status NCT01090895 Phase 4 Vitamin C;Placebo
20 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4 Nicorandil;normal saline
21 Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Unknown status NCT02446730 Phase 4 Prasugel;Clopidogrel
22 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4 Prasugrel;Bivalirudin;Clopidogrel;Heparin
23 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
24 Desflurane-induced Myocardial Protection Unknown status NCT02019797 Phase 4 Desflurane
25 Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Unknown status NCT02233790 Phase 4 Ticagrelor;Clopidogrel
26 Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) Unknown status NCT01035528 Phase 4 insulin glargine;metformin
27 Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI Unknown status NCT02792712 Phase 4 Ticagrelor;Clopidogrel
28 CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS Unknown status NCT00933400 Phase 4
29 Multifactorial Intervention in Type 2 Diabetes - Italy Unknown status NCT01240070 Phase 4
30 Xience/Promus for Long Coronary Lesion Registry Unknown status NCT01147237 Phase 4
31 Treatment of Coronary In-Stent Restenosis Unknown status NCT01735825 Phase 4
32 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4 omeprazole;Pantoprazole
33 Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial Unknown status NCT00700856 Phase 4 add-on pioglitazone;add-on sulphonylurea
34 Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation Unknown status NCT02666157 Phase 4 Dabigatran etexilate;Rivaroxaban;Apixaban
35 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4 valsartan
36 The Pacing vs No Pacing Study - PNP Study Unknown status NCT02498639 Phase 4
37 The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI Unknown status NCT02658838 Phase 4 Ticagrelor;full amount low molecular weight heparin;half amount low molecular weight heparin;No low molecular weight heparin
38 Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction Completed NCT02291796 Phase 4 Bezafibrate
39 Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction Completed NCT00302419 Phase 4 intracoronary infusion,
40 GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction Completed NCT00538317 Phase 4 tirofiban;tirofiban
41 REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction Completed NCT01381185 Phase 4 Aspirin 200mg qd, Clopidogrel 2x75mg qd
42 Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial Infarction Completed NCT00863629 Phase 4 Insulin
43 The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction Completed NCT00882466 Phase 4 human recombinant erythropoietin
44 BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial. Completed NCT01696110 Phase 4 Bivalirudin;heparin;heparin plus tirofiban
45 Southwest German Interventional Study in Acute Myocardial Infarction III Completed NCT01124890 Phase 4
46 Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction Completed NCT00712894 Phase 4 Diltiazem;Verapamil;Nitroglycerin
47 Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction Completed NCT00882739 Phase 4 Clopidogrel 300 mg;Clopidogrel 600 mg;Clopidogrel 900 mg
48 Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction Completed NCT00627809 Phase 4 Streptokinase
49 Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction Completed NCT00536887 Phase 4 atorvastatin
50 Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI) Completed NCT00827788 Phase 4 Iodixanol;Iopromide

Search NIH Clinical Center for Acute Myocardial Infarction

Genetic Tests for Acute Myocardial Infarction

Anatomical Context for Acute Myocardial Infarction

MalaCards organs/tissues related to Acute Myocardial Infarction:

42
Heart, Bone, Bone Marrow, Endothelial, Kidney, Testes, Brain

Publications for Acute Myocardial Infarction

Articles related to Acute Myocardial Infarction:

(show top 50) (show all 6652)
# Title Authors Year
1
Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States. ( 30874787 )
2019
2
Cardiac Sympathetic Afferent Denervation Protects Against Ventricular Arrhythmias by Modulating Cardiac Sympathetic Nerve Activity During Acute Myocardial Infarction. ( 30877783 )
2019
3
Comparison of 0.9-mm and 1.4-mm catheters in excimer laser coronary angioplasty for acute myocardial infarction. ( 30879227 )
2019
4
Do-Not-Resuscitate Status and Risk-Standardized Mortality and Readmission Rates Following Acute Myocardial Infarction. ( 30879325 )
2019
5
Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention. ( 30882670 )
2019
6
Predictive value of blood urea nitrogen/creatinine ratio in the long-term prognosis of patients with acute myocardial infarction complicated with acute heart failure. ( 30882678 )
2019
7
Characteristics and outcomes of patients with cancer presenting with acute myocardial infarction. ( 30883428 )
2019
8
Identification of Candidate Genes and MicroRNAs for Acute Myocardial Infarction by Weighted Gene Coexpression Network Analysis. ( 30886860 )
2019
9
Re: Association of the Hospital Readmissions Reduction Program with Mortality among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. ( 30888900 )
2019
10
Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Addition to High-Sensitivity Troponin I in Early Diagnosis of Acute Myocardial Infarction. ( 30889909 )
2019
11
Heartbeat: Improving acute myocardial infarction outcomes in women. ( 30890615 )
2019
12
Novel Acute Myocardial Infarction Risk Stratification (nARS) System Reduces the Length of Hospitalization for Acute Myocardial Infarction. ( 30890684 )
2019
13
Corrigendum to: The unique mechanism of functional mitral regurgitation in acute myocardial infarction: a prospective dynamic 4D quantitative echocardiographic study. ( 30891587 )
2019
14
Benefit of Early Statin Therapy in Acute Myocardial Infarction in Korea. ( 30891965 )
2019
15
Disparities In The Use Of Drug-eluting Stents For Diabetic Patients With ST-elevation Acute Myocardial Infarction Assisted In the Public versus Private Network - VICTIM Register. ( 30892386 )
2019
16
Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low density lipoprotein cholesterol levels. ( 30894407 )
2019
17
Computerized Tomography is an Effective Modality to Evaluate Iatrogenic Aortocoronary Dissection with Acute Myocardial Infarction. ( 30895759 )
2019
18
Isobaric tags for relative and absolute quantitation‑based proteomics reveals potential novel biomarkers for the early diagnosis of acute myocardial infarction within 3 h. ( 30896787 )
2019
19
Testosterone deficiency reduces the effects of late cardiac remodeling after acute myocardial infarction in rats. ( 30897106 )
2019
20
Geographic variation in inpatient costs for Acute Myocardial Infarction care: Insights from Italy. ( 30902531 )
2019
21
In-hospital Takotsubo syndrome versus in-hospital acute myocardial infarction among patients admitted for non-cardiac diseases: a nationwide inpatient database study. ( 30903314 )
2019
22
Clinical case of successful management of acute myocardial infarction during pregnancy. ( 30903792 )
2019
23
An unusual aetiology for acute myocardial infarction. ( 30904508 )
2019
24
Missed Acute Myocardial Infarction (MAMI) in a rural and regional setting. ( 30906847 )
2019
25
Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis. ( 30909587 )
2019
26
Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study. ( 30909774 )
2019
27
Acute myocardial infarction in pregnancy: spasm caused by hyperthyroidism? ( 30909844 )
2019
28
Association of in-hospital resource utilization with post-acute spending in Medicare beneficiaries hospitalized for acute myocardial infarction: a cross-sectional study. ( 30909904 )
2019
29
Cyclic helix B peptide ameliorates acute myocardial infarction in mice by inhibiting apoptosis and inflammatory responses. ( 30911412 )
2019
30
Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital. ( 30911482 )
2019
31
Falciparum malaria mimicking acute myocardial infarction. ( 30911529 )
2019
32
Early Effects of Atorvastatin on Vitamin D and Parathyroid Hormone Serum Levels Following Acute Myocardial Infarction. ( 30911557 )
2019
33
Developing LRP1 Agonists into a Therapeutic Strategy in Acute Myocardial Infarction. ( 30696029 )
2019
34
Biomarkers in acute myocardial infarction: current perspectives. ( 30697054 )
2019
35
Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction. ( 30698697 )
2019
36
Association between time of hospitalization with acute myocardial infarction and in-hospital mortality. ( 30698766 )
2019
37
International comparison of acute myocardial infarction care and outcomes using quality indicators. ( 30700519 )
2019
38
Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up. ( 30700627 )
2019
39
Response to: Soluble regulators of Interleukin-1 signaling: Novel biomarkers for early acute myocardial infarction diagnosis and to predict ischemia/reperfusion injury? ( 30704648 )
2019
40
Antidepressant prescription in acute myocardial infarction is associated with increased mortality 1 year after discharge. ( 30704672 )
2019
41
Increased Serum CA125 and Brain-Derived Neurotrophic Factor (BDNF) Levels on Acute Myocardial Infarction: A Predictor for Acute Heart Failure. ( 30706901 )
2019
42
Simultaneous colorimetric determination of acute myocardial infarction biomarkers by integrating self-assembled 3D gold nanovesicles into a multiple immunosorbent assay. ( 30707310 )
2019
43
Long-term impact of acute kidney injury on prognosis in patients with acute myocardial infarction. ( 30711262 )
2019
44
Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction. ( 30712488 )
2019
45
Socioeconomic status and depression as combined risk factors for acute myocardial infarction and stroke: A population-based study of 2.7 million Korean adults. ( 30712815 )
2019
46
Mortality with antidepressants after acute MI: Antidepressant use after acute myocardial infarction (MI) is associated with an increased mortality 1 year after discharge from Swiss hospitals. ( 30715283 )
2019
47
Readmission and mortality in patients ≥70 years with acute myocardial infarction or heart failure in the Netherlands: a retrospective cohort study of incidences and changes in risk factors over time. ( 30715672 )
2019
48
Functional genetic variants of the GATA4 gene promoter in acute myocardial infarction. ( 30720078 )
2019
49
Influence of MiR-154 on myocardial apoptosis in rats with acute myocardial infarction through Wnt/β-catenin signaling pathway. ( 30720190 )
2019
50
Diagnostic role of echocardiography in patients admitted to the emergency room with suspect no-ST-segment elevation acute myocardial infarction. ( 30720191 )
2019

Variations for Acute Myocardial Infarction

Copy number variations for Acute Myocardial Infarction from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 210497 6 30400000 36600000 Amplification C4B Acute myocardial infarction

Expression for Acute Myocardial Infarction

LifeMap Discovery
Genes differentially expressed in tissues of Acute Myocardial Infarction patients vs. healthy controls: 35
# Gene Description Tissue Up/Dn Fold Change (log2) P value
1 EGR3 early growth response 3 Blood + 5.52 0.000
2 LOC286058 uncharacterized LOC286058 Blood + 4.73 0.000
3 CXCL8 chemokine (C-X-C motif) ligand 8 Blood + 3.51 0.004
4 LEP leptin Heart + 3.45 0.011
5 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein Blood + 3.18 0.007
Search GEO for disease gene expression data for Acute Myocardial Infarction.

Pathways for Acute Myocardial Infarction

Pathways related to Acute Myocardial Infarction according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 9.98 ACE PLAT

GO Terms for Acute Myocardial Infarction

Cellular components related to Acute Myocardial Infarction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.23 ACE CRP F3 FABP3 MIR29A NPPB

Biological processes related to Acute Myocardial Infarction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of vascular endothelial cell proliferation GO:1905564 9.26 MIR29A MIR499A
2 heart contraction GO:0060047 9.16 ACE TNNI3
3 regulation of blood vessel diameter GO:0097746 8.96 ACE NPPB
4 transition between fast and slow fiber GO:0014883 8.62 MIR208B MIR499A

Sources for Acute Myocardial Infarction

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....